OCGN Stock

Ocugen (OCGN) Stock Has Risen 196% So Far This Year, What's Next?

Ocugen (NASDAQ: OCGN) stock was in fluctuating state in recent days. COVAXIN vaccine, the company was jointly developed with its Indian partner, Bharat Biotech, has received a lot of attention from investors this year. The company's stock has risen by 196% YTD.
www.investreader.com - May 20, 2021

Why Ocugen (OCGN) Stock Fell 39% In Three Days?

Ocugen (NASDAQ: OCGN) stock reached its highest point this year on Monday, then started to fall. The stock fell by nearly 39% over the past three trading days.
www.investreader.com - May 06, 2021

How To Trade Ocugen (OCGN) Stock Currently, Buy or Sell?

Ocugen (NASDAQ: OCGN) stock is under selling pressure as the company issued an aggregate of 10 million shares of its common stock priced at a premium to market in recent day.
www.investreader.com - April 28, 2021

Why ZOM, NAKD, AMC, OCGN And Other Reddit Stocks Soared Monday?

Very large retail buyers on Reddit and other social media sites are taking concerted action to drive up the price of these stocks.
www.investreader.com - April 27, 2021

Will Ocugen (OCGN) Stock Continue To Rise Next Week?

Reportedly that the price of the COVAXIN vaccine seems a bit high in India.
www.investreader.com - April 26, 2021

Where Is The Hope For Ocugen (OCGN) COVID-19 Vaccine?

OCGN‘s COVAXIN vaccine can significantly limit the spread of asymptomatic COVID-19 infections based on efficacy shown to date.
www.investreader.com - April 22, 2021

Why Ocugen (OCGN) Stock Worth To Buy?

Ocugen's current stock was obviously undervalued if it can achieve success through COVAXIN and OCU400.
www.investreader.com - April 14, 2021

OCGN Stock: Why Ocugen Stock Rose 8.5% On Wednesday?

According to Reuters, Mexican Foreign Minister Marcelo Ebrard said on Tuesday that Mexico’s health regulator Cofepris has authorized the emergency use of India’s COVID-19 vaccine COVAXIN.
www.investreader.com - April 08, 2021

OCGN Stock: Is Ocugen Stock Still Worth Watching After Multiple Vaccines Came Out?

Ocugen believes that the COVAXIN vaccine will have great opportunity in the United States.
www.investreader.com - April 04, 2021

OCGN Stock: Why Ocugen Stock Rose Today?

Although there have been some successful COVID-19 vaccines on the market, but the Ocugen's COVAXIN vaccine still has a chance.
www.investreader.com - March 31, 2021

OCGN Stock: 3 Key Catalysts That Could Send This Stock Soaring Again

Investors in OCGN stock have seen shares settle down quite a bit of late, but there's room to be optimistic with this biotech stock.
investorplace.com - March 24, 2021

OCGN Stock: Ocugen Is Not One to Trust With Nest Egg Funds

There is too much riding on hope for OCGN stock. It is OK to trade it but fundamental investments are too risky for most.
investorplace.com - March 19, 2021

Keep Your Eyes on OCGN Stock as It May Move Back to $20 Soon

OCGN stock has swung wildly since Ocugen pivoted towards Covid-19 vaccine development, but recently reported data suggests a bright outlook.
investorplace.com - March 18, 2021

OCGN Stock: Red-Hot Ocugen Eyes U.S. Vaccine Launch in Q2

OCGN stock just got a big boost. According to a new report, Ocugen plans to launch its Covid-19 vaccine in the U.S. soon.
investorplace.com - March 15, 2021

OCGN Stock: 3 Big Reasons Ocugen Is Rocketing Higher Today

Investors in OCGN stock have a number of catalysts to point to today as reasons to hold onto this outperforming stock.
investorplace.com - March 11, 2021

Is OCGN Stock worth $18 or Just a Couple of Bucks?

Ocugen's roller-coaster ride continues. OCGN stock lost more than 14% on March 5. Is it an $18 stock or worth just a couple of bucks?
investorplace.com - March 08, 2021

OCGN Stock: Ocugen Flies on COVID-19 News - CNA Finance

OCGN stock is screaming for the top after the company announced positive Phase 3 results from a COVID-19 vaccine.
cnafinance.com - March 04, 2021

With Vaccine Distribution Profits Possible, Keep an Eye on OCGN Stock

Ocugen partnered on development of a Covid-19 vaccine. This could work wonders for OCGN stock, but it's a race to get to market in time.
investorplace.com - March 03, 2021

OCGN Stock: Why Covid-19 Vaccine Play Ocugen Is Shooting Higher Today

OCGN stock is on the move today after vaccine partner Bharat Biotech shared positive interim results from its Phase 3 trials.
investorplace.com - March 03, 2021

OCGN Stock: What to Know About Red-Hot Ocugen and the India Vaccination News

OCGN stock is pulling back after a Friday rally. Here's one big piece of news that could restore faith in Ocugen shares.
investorplace.com - March 01, 2021

OCGN Stock: 2 Big Reasons Ocugen Shares Are Soaring Today

OCGN stock is on the move today thanks to two big headlines about its Covid-19 vaccine plans. Here's what to know.
investorplace.com - February 26, 2021

OCGN Stock: Why Red-Hot Ocugen Is on the Move Today

OCGN stock is on the move today after receiving orphan drug status for its OCU400 from the European Commission. Here's what to know.
investorplace.com - February 24, 2021

OCGN Stock: Why You Should Keep Your Distance from Ocugen

Off and on the price chart OCGN stock, today's reality is bleak for shareholders, but being a bear poses its own challenges.
investorplace.com - February 23, 2021

OCGN Stock Is Worth 24% More Using Scenario and Probability Analysis

Ocugen could still be undervalued. OCGN stock could be worth $12.64 per share, 24% higher, using scenario and probability analysis.
investorplace.com - February 22, 2021

Why Investors Should Pay Attention to Soaring OCGN Stock

OCGN stock has been on a tear in recent months on speculation its therapeutics aimed at curing blindness could dominate its potential market.
investorplace.com - February 22, 2021

OCGN: Ocugen: Buy, Sell, or Hold? | StockNews.com

Ocugen, Inc.(NASDAQ:OCGN): Although shares of Ocugen (OCGN) have rallied over the past month in response to the company’s announcement of plans to co-develop a COVID-19 vaccine candidate with India’s Bharat Biotech, the vaccine’s commercialization prospects look bleak. In addition to that, given the stock’s high valuation even though the company has no revenue-generating products in the market, we think the stock may not worth the risk.
stocknews.com - February 12, 2021

OCGN Stock Price: $13 Target (Up From $0.70) By Chardan Capital

The stock price of Ocugen Inc (NASDAQ: OCGN) has received a price target increase by Chardan Capital. These are the details.
pulse2.com - February 09, 2021

OCGN Stock Price Increases Over 150%: Why It Happened

The stock price of Ocugen Inc (NASDAQ: OCGN) is trading at over 150% as of 11:26 AM ET today. This is why it happened.
pulse2.com - February 08, 2021

OCGN Stock: Ocugen Climbs on Offering at a Premium - CNA Finance

OCGN stock is screaming for the top in the market this morning, squeezing the shorts after announcing a fund raise at a compelling premium.
cnafinance.com - February 08, 2021

OCGN Stock: Why Ocugen Shares Are Rocketing Higher Again Today

OCGN stock is continuing its February rollercoaster on Monday, rallying another 60% after announcing a direct common stock offering.
investorplace.com - February 08, 2021